Bmx is a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Bmx is characterized by an N-terminal pleckstrin homology domain and has been shown to be a downstream effector of phosphatidylinositol 3-kinase. P21-activated kinase 1 (Pak1), another well characterized effector of phosphatidylinositol 3-kinase, has been implicated in the progression of breast cancer cells.
货号 | 产品名 | Cas | 产品描述 |
---|---|---|---|
PC16024 | BMX-IN-1 | 1431525-23-3 | BMX(又称ETK)激酶抑制剂,BMX-IN-1是BMX 激酶,IC50 值为8.0 nM。 |
PL01203 | CHMFL-BMX-078 | 1808288-51-8 | CHMFL-BMX-078是高效的,选择性的,不可逆的,类型II BMX激酶抑制剂,IC50值为11 nM。 |
PL01718 | Poseltinib | 1353552-97-2 | Poseltinib 是一种具有口服活性,选择性,不可逆的小分子Bruton酪氨酸激酶 (BTK) 抑制剂,IC50 为 1.95 nM,对 BMX,TEC 和 TXK 的选择性作用分别是 0.3,2.3 和 2.4 倍。Poseltinib可共价结合 BTK 的活性位点 (半胱氨酸 481 残基),同时有效抑制 B 细胞受体 (BCR),Fc受体 (FcR),Toll样受体 (TLR) 介导的信号传导。 |